Pancreas

Published by: Lippincott Williams & Wilkins  

People

  1. Reidy
    Reidy
  2. Raj
    Raj
  3. Bodei
    Bodei
  4. O'Reilly
    O'Reilly
  5. Tang
    Tang
  6. Capanu
    Capanu
  7. Chou
    Chou
  8. Saltz
    Saltz
  9. Basturk
    Basturk
  10. Untch
    Untch

Groups

  1. Center for Pancreatic Cancer Research (68)
  2. Department of Medicine (64)
  3. Solid Tumor Oncology Division (59)
  4. Gastrointestinal Oncology Service (58)
  5. Sloan Kettering Institute Postdocs (24)
  6. Radiology, Department of (23)
  7. Epidemiology and Biostatistics (19)
  8. Molecular Imaging and Therapy Service (17)
  9. Surgery (17)
  10. Biostatistics Service (14)
Search Within
Formats
  1. Meeting Abstract (68)
  2. Journal Article (40)
  3. Review (3)
  4. Guidelines (2)
  5. Correspondence (1)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (68)
  2. Department of Medicine (64)
  3. Solid Tumor Oncology Division (59)
  4. Gastrointestinal Oncology Service (58)
  5. Sloan Kettering Institute Postdocs (24)
  6. Radiology, Department of (23)

More Groups

People
  1. Diane Reidy (43)
  2. Nitya Raj (27)
  3. David Klimstra (21)
  4. Lisa Bodei (16)
  5. Eileen O'Reilly (12)
  6. Laura Tang (12)

More People

Years
  1. 2022 (11)
  2. 2021 (10)
  3. 2020 (9)
  4. 2019 (10)
  5. 2018 (15)
  6. 2017 (15)

More Years

Publishers
  1. Lippincott Williams & Wilkins (116)

Results (116)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Helping patients understand pancreatic cancer using animated pancreas patient education with visual formats of learning
    Journal Article

    Munigala, S.; Gardner, T. B.; O'Reilly, E. M.; Fernández-Del Castillo, C.; Ko, A. H.; Pleskow, D.; Vollmer, C. M. Jr; Searle, N. A.; Bakelman, D.; Holt, J. M.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Safety, pharmacodynamic, and antitumor activity of tidutamab, an SSTR2 x CD3 bispecific antibody, in subjects with advanced neuroendocrine tumors
    Meeting Abstract

    El-Rayes, B. F.; Hendifar, A. E.; Pant, S.; Wilky, B. A.; Reilley, M. J.; Benson, A. B.; Chow, W. A.; Konda, B.; Starr, J.; Ahn, D. H.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Early onset well-differentiated pancreatic neuroendocrine tumors: clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C.; Reidy-Lagunes, D.; Wei, A.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab-based therapy in previously treated extrapulmonary poorly-differentiated neuroendocrine carcinomas: Results of part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Hope, T. A.; Kolli, K. P.; Zhang, L.; Fattah, D.; Calabrese, S.; Grabowsky, J. A.; Perez, K.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • The phase 3 NETTER-1 study of (177)Lu-DOTATATE in patients with midgut neuroendocrine tumors: Updated progression-free survival analyses
    Meeting Abstract

    Kunz, P. L.; Benson, A.; Bodei, L.; Grande, E.; Mittra, E.; Kulke, M. H.; Yao, J. C.; Wolin, E. M.; Niepel, D.; Demange, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms (NENs) treated in the "modern era": A multicenter retrospective review
    Meeting Abstract

    Le, B. K.; McGarrah, P. W.; Whitman, J.; Paciorek, A.; Raj, N.; Reidy-Lagunes, D.; Hauser, H.; Le, T.; Del Rivero, J.; Apolo, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save

    • Pancreas – authorized name for:

    Name ISSN / ISBN Publisher
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Unknown
    Pancreas 08853177 Unknown
    Pancreas 0885-3177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Lippincott-Raven
    Pancreas 08853177 Wolters Kluwer Health, Inc
    Pancreas 15364828 Unknown
    Pancreas 15364828 Lippincott Williams & Wilkins
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 15364828 Wolters Kluwer Health, Inc